Circulation Journal · 2023 · 61 citations · 20 references
AMICS treatment with Impella showed favorable 30-day survival and safety profiles. The survival rate of patients treated with Impella alone was particularly high. Further studies are needed to improve outcomes of patients with ECPELLA support.
20
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock
Benedikt Schrage, Karim Ibrahim, Tobias Loehn et al. · Circulation · 2019 · 489 citations · Full text